Shilpa Medicare Board to Consider Unaudited Financial Results

The Board of Directors of Shilpa Medicare Limited is scheduled to meet on February 06, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. The trading window, which was closed from January 01, 2026, will remain closed until 48 hours after the declaration of the unaudited financial results.

Board Meeting Announcement

A meeting of the Board of Directors of Shilpa Medicare Limited will be held on Friday, February 06, 2026. The primary agenda is to review and approve the unaudited financial results of the company. This pertains to the financial performance for the quarter and nine-month period concluding on December 31, 2025 (Q3).

Trading Window Closure

In accordance with company policy and regulatory guidelines aimed at preventing insider trading, the trading window for dealing in the company’s securities has been closed. This closure came into effect on January 01, 2026, and will remain in place until 48 hours following the official declaration of the aforementioned financial results. This measure ensures fair and transparent trading practices.

Source: BSE

Previous Article

Brigade Group Signs Agreement to Purchase Land in Secunderabad for ₹650 Cr Project

Next Article

UltraTech Cement Q3 FY26 Earnings Call Transcript Highlights Strong Demand